INSIGHTS ON SOLID DOSE MANUFACTURING

  • How To Handle Intrinsic Product Powder Particles

    Powder filling creates intrinsic particles that interfere with continuous monitoring. Risk‑based strategies must separate product dust from true contamination to meet Annex 1 requirements.

  • Contract Pharma 2026: Mikart On CDMO Collaboration

    An overview of a milestone pharmaceutical outsourcing conference focused on CDMO collaboration, tech transfer, and oral solid and liquid dose manufacturing strategies.

     

  • Blending And Simulation: A Beginner's Guide

    This beginner-friendly webinar reveals essential steps to understand mixing, reduce segregation, enhance efficiency, and improve product quality with granular materials.

  • Blister Solutions

    With over 6,000 tooling parts and an in-house machining center to ensure precision, explore this versatile blister service that provides both Thermoformed and Cold-Formed solutions.

SOLID DOSE MANUFACTURING SOLUTIONS

  • Ropack Pharma Solutions recognizes the significance of manufacturing in generating pharmaceutical and nutraceutical products which meet the highest standards. With precision as our goal, we offer blending and encapsulation services in cGMP-compliant facilities utilizing gold-standard technology. 

  • A global, integrated approach to oral solid dosage development combines formulation science, advanced delivery, and scalable manufacturing to support efficient clinical progress and reliable supply.

  • Standard and customized 2D and 3D fluid containment systems. With a wealth of experience, knowledge, and solid quality processes behind every Thermo Scientific™ product, we will help you feel assured that your bioproduction process performs at its best.

  • Using single-use technologies to achieve continuous manufacturing has long been a goal of biomanufacturers. At ILC Dover, we have focused on developing premier films for a wide array of powder handling and containment needs. As a result, our engineers have created cutting-edge films designed to provide unmatched performance characteristics, while increasing handling speed and safety.

  • With many of the blockbuster biologic drugs of the ’90s are coming off of patent, companies are racing to provide a clinically similar alternative to these pioneering products. Like any biologic drug, they require care and attentiveness throughout the manufacturing process. Therefore, it is necessary to maintain aseptic conditions throughout the production process of these drug products.